Renin inhibitors

Details for Australian Patent Application No. 2008288648 (hide)

Owner Merck Frosst Canada Ltd.

Inventors McKay, Daniel; Roy, Patrick; Juteau, Helene; Gallant, Michel; Fortin, Rejean; Lacombe, Patrick; Dube, Daniel; Aspiotis, Renee; Wu, Tom Yao-Hsiang

Agent Spruson & Ferguson

Pub. Number AU-A-2008288648

PCT Pub. Number WO2009/023964

Priority 60/965,377 20.08.07 US

Filing date 18 August 2008

Wipo publication date 26 February 2009

International Classifications

C07C 217/54 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61K 31/277 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

C07C 233/00 (2006.01) Carboxylic acid amides

C07C 237/00 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 255/00 (2006.01) Carboxylic acid nitriles

C07C 271/00 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07D 213/04 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

4 February 2010 PCT application entered the National Phase

  PCT publication WO2009/023964 Priority application(s): WO2009/023964

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008288651-Process for converting 9-dihydro-13-acetylbaccatin III into docetaxel or paclitaxel

2008288645-PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease